Login to Your Account



Washington Roundup

FDA Faces Challenge of Dealing With Scientific Uncertainty

By Mari Serebrov
Washington Editor

Monday, January 9, 2012

WASHINGTON – Regulatory uncertainty at the FDA is often cited as a source of industry heartburn. But rather than turning down the heat, the agency is looking for ways to make that uncertainty less irritating, recognizing it as a natural part of the scientific process.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription